Anthem Blue Cross and Blue Shield Virginia prior authorization, page 42

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
86807Serum Screening, Cytotoxic Percent Reactive Antibody (Pra); Standard MethodVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86808Serum Screening, Cytotoxic Percent Reactive Antibody (Pra); Quick MethodVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86812Hla Typing; A, B, Or C, Single AntigenVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86813Hla Typing; A, B, Or C, Multiple AntigensVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86816Hla Typing; Dr/Dq, Single AntigenVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86817Hla Typing; Dr/Dq, Multiple AntigensVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86821Hla Typing; Lymphocyte Culture, Mixed (Mlc)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86825Human leukocyte antigen (HLA) crossmatch, non-cytotoxic (eg, using flow cytometry); first serum sample or dilutionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86828Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, flow cytometry); qualitative assessment of the presence or absence of antibodVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86829Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); qualitative assessment of the presence or absence of antibodVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86830Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); antibody identification by qualitative panel using completeVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86831Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); antibody identification by qualitative panel using completeVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86832Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); high definition qualitative panel for identification of antiVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86833Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); high definition qualitative panel for identification of antiVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86834Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); semi-quantitative panel (eg, titer), HLA Class IVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86835Antibody to human leukocyte antigens (HLA), solid phase assays (eg, microspheres or beads, ELISA, Flow cytometry); semi-quantitative panel (eg, titer), HLA Class IIVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86850Antibody Screen, Rbc, Each Serum TechniqueVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86860Antibody Elution (Rbc), Each ElutionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 49 Original policy
86870Antibody Identification, Rbc Antibodies, Each Panel, Each Serum TechniqueVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86880Antihuman Globulin Test (Coombs Test); Direct, Each AntiserumVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86885Antihuman globulin test (Coombs test); indirect, qualitative, each reagent red cellVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86886Antihuman globulin test (Coombs test); indirect, each antibody titerVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86890Autologous Blood/Component, Collect/Process/Storage; PredepositedVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86891Autologous Blood/Component, Collect/Process/Storage; Intra-/Postoperative SalvageVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86900Blood Typing; AboVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86901Blood Typing; Rh (D)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86902Blood typing; antigen testing of donor blood using reagent serum, each antigen testVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86904Blood Typing; Antigen Screening, Compatible Unit Using Patient Serum, Per Unit ScreenedVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86905Blood Typing; Rbc Antigens, Other Than Abo/Rh (D), EachVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86906Blood Typing; Rh Phenotyping, CompleteVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86910Blood Typing, Paternity Testing, Per Individual; Abo, Rh & MnVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86920Compatibility Test Each Unit; Immediate Spin TechniqueVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86921Compatibility Test Each Unit; Incubation TechniqueVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86922Compatibility Test Each Unit; Antiglobulin TechniqueVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86923Compatibility test each unit; electronicVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86927Fresh Frozen Plasma, Thawing, Each UnitVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86930Frozen Blood, Each Unit; Freezing (W/Preparation)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86931Frozen Blood, Each Unit; ThawingVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86932Frozen Blood, Each Unit; Freezing (W/Preparation)& ThawingVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86940Hemolysins & Agglutinins; Auto, Screen, EachVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86941Hemolysins & Agglutinins; IncubatedVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86945Irradiation, Blood Product, Each UnitVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86950Leukocyte TransfusionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86960Volume reduction of blood or blood product (eg, red blood cells or platelets), each unitVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86965Pooling, Platelets/Other Blood ProductsVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86970Pretreatment Rbc's, Antibody Detection/Id/Compatibility; Incubation W/Chemicals/Drugs, EachVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86971Pretreatment Rbc's, Antibody Detection/Id/Compatibility; Incubation W/Enzymes, EachVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86972Pretreatment Rbc's, Antibody Detection/Id/Compatibility; Density Gradient SeparationVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86975Pretreatment, Serum, Use In Rbc Antibody Identification; Incubation W/Drugs, EachVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy
86976Pretreatment, Serum, Use In Rbc Antibody Identification; DilutionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 50 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.